One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Valve Underexpansion and Clinical Outcomes With ACURATE neo2: Findings From the ACURATE IDE Trial
Stent Frame Underexpansion: A Common Pathway for Failed Interventional Procedures?
Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial
Body Mass Index, Central Adiposity, and HFpEF: Some Answers But More Questions
Heart Failure Care and Outcomes After Private Equity Acquisition of U.S. Hospitals
Private Equity in Heart Failure Care: Where Chronic Disease and Acute Financial Pressures Collide
Aortic Stenosis and Mitral Regurgitation: Takeaways From the Heart Valve Collaboratory Workshop on Multivalvular Disease
Outcomes in Older Patients Undergoing Surgical Aortic Valve Replacement With Concomitant Procedures
Misclassification of Myocardial Infarction Subtypes in Administrative Claims: Implications for Clinical Epidemiology and Quality Assessment
Anticoagulants for Atrial Fibrillation in Survivors of Intracranial Hemorrhage: A Meta-Analysis of Randomized Trials
Evolution of Critical Care Cardiology: An Update on Structure, Care Delivery, Training, and Research Paradigms: A Scientific Statement From the American Heart Association
Amara Yad Image: Interior View of the Right Atrium and Right Ventricle
Reducing Cardiovascular Events With Early Ezetimibe: Getting to “Europe on Target� From “Jena auf Ziel�
Albuminuria Range as a Key Metric Linking Renal Function to Heart Failure Outcome in FINEARTS-HF
Teleprehabilitation Before Cardiac Surgery: Are There Benefits or Biases in Current Metrics?
Reply: Teleprehabilitation Before Cardiac Surgery: Are There Benefits or Biases in Current Metrics?
Reply: Are Benefits of Early Ezetimibe Conferred by its Effect on LDL-C?
Is the Efficacy of Finerenone Related to Obesity Type or Explained by the Obesity Paradox in HFmrEF/HFpEF?
The Role of Geriatric Expertise on Cardiovascular Outcomes When Cardiologists Are Employed by Hospitals
Intra-Aortic Balloon Pump in Heart Failure–Related Cardiogenic Shock: Dead or Alive?
